Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Kazuhiro Yoshida(Nagasaki University), Tetsuya Toge(Hiroshima University), Norihisa Takakura(Fukuyama City Hospital), Naoki Hirabayashi(Hiroshima University), Masahiko Nishiyama(Hiroshima University), Wataru Takiyama, Jyunnichi Sakamoto, Motoki Ninomiya
PubMed
September 9, 2004
Cited by 46
Related Papers
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255